Loading clinical trials...

Prevalence Study of Gastrointestinal Risk Factors in Patients With Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS). | Clinical Trials | Clareo Health

COMPLETED

Prevalence Study of Gastrointestinal Risk Factors in Patients With Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS).

Prevalence Study of Gastrointestinal Risk Factors in Patients With Osteoarthritis, Rheumatoid Arthritis and Ankylosing Spondylitis Receiving Treatment With Non- Steroidal Anti- Inflammatory Drugs.

NCT01577563•AstraZeneca

View on ClinicalTrials.gov

Summary

RATIONAL is a multinational, multicentre, observational, cross sectional study of adult patients in treatment with NSAID therapy for OA, RA or AS during for at least 2 weeks before study visit (at least one dose).

Detailed Description

Prevalence study of gastrointestinal risk factors in patients with osteoarthritis, rheumatoid arthritis and ankylosing spondylitis receiving treatment with non- steroidal anti- inflammatory drugs.

Eligibility

Age

21 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Provision of subject informed consent.
•Female and/or male, aged \> 21 years.
•Patients diagnosis with RA (ACR 1987 or ACR/EULAR 2010 criteria), OA (ACR 1986, 1990 and 1991 criteria) or AS (New York 1984 criteria or ESSG 2002 criteria) (documented in the medical record).
•Patients receiving at least one dose of NSAIDs.

Exclusion Criteria

•Participation in any interventional study involving investigational drugs.
•Patient refuses to fill in the study questionnaires.
•Pregnant or breastfeeding women.
•Patients with active neoplastic disease in the last 5 years, except basal-cell carcinoma.

Locations (85)

Research Site

Avellaneda, Argentina, Argentina

Research Site

Bahía Blanca, Argentina, Argentina

Research Site

Banfield, Argentina, Argentina

Research Site

Campana, Argentina, Argentina

Research Site

Capital Federal, Argentina, Argentina

Research Site

Corrientes, Argentina, Argentina

Research Site

La Plata, Argentina, Argentina

Research Site

Luján, Argentina, Argentina

Research Site

Mar del Plata, Argentina, Argentina

Research Site

Mendoza, Argentina, Argentina

Key Dates

Start Date

May 1, 2012

Primary Completion Date

March 1, 2013

Completion Date

March 1, 2013

Last Updated

May 14, 2013

Enrollment

5,383

ACTUAL participants

Conditions

Osteoarthritis (OA)Rheumatoid Arthritis (RA)Ankylosing Spondylitis (AS)

A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Autoimmune Rheumatic Diseases

NCT06647069

Systemic Lupus Erythematosus (SLE)Rheumatoid Arthritis (RA)

View study

RECRUITING

Clinical Cohort Construction and Therapeutic Effect Evaluation of Integrated Traditional Chinese and Western Medicine in the Treatment of Rheumatoid Arthritis

NCT07484243

Rheumatoid Arthritis (RA)Rheumatoid Arthritis-Associated Interstitial Lung Disease+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 14, 2013Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Prevalence Study of Gastrointestinal Risk Factors in Patients With Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS).

Inclusion Criteria

Exclusion Criteria

A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Autoimmune Rheumatic Diseases

Clinical Cohort Construction and Therapeutic Effect Evaluation of Integrated Traditional Chinese and Western Medicine in the Treatment of Rheumatoid Arthritis

Plant-Based Diet for Patients With Rheumatoid Arthritis

Mako Cementless TKA vs Mako Cemented TKA

Neurolysis for the Treatment of Medial Chronic Knee Pain Due to Osteoarthritis

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.